Back to top
more

Zimmer Biomet (ZBH)

(Real Time Quote from BATS)

$114.48 USD

114.48
787,815

-1.69 (-1.46%)

Updated Sep 4, 2024 03:49 PM ET

After-Market: $114.50 +0.02 (0.02%) 4:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. With operations in over 25 countries, Zimmer markets products in more than 100 countries. In 2015, Zimmer Holdings, Inc. (the legacy company) acquired Biomet, Inc. to form a new consolidated company.

Zimmer Biomet (ZBH) Down 2.9% Since Earnings Report: Can It Rebound?

Zimmer Biomet (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Zimmer Biomet New System Gets FDA Nod, to Boost Spine Wing

    Zimmer Biomet (ZBH) receives FDA's approval for the new system, which is likely to augment the company's lumbar spacers portfolio.

      Generac, Maximus, Norbord, Boeing and Zimmer Biomet as Zacks Bull and Bear of the Day

      Generac, Maximus, Norbord, Boeing and Zimmer Biomet as Zacks Bull and Bear of the Day

        Taye Baldinazzo headshot

        3 Stocks Back In Play After U.S.-China Trade War Stalls

        On Sunday, the U.S. and China put trade tensions aside in hopes of reaching a stable and broad trade agreement. With previously at-risk stocks beginning to rise, there seems to be room for profit in these formerly questionable markets. Read on for three stocks that investors should reconsider as the trade war is put on hold.

          Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, Margins Drop

          Zimmer Biomet (ZBH) issues full-year 2018 sales and earnings guidance in Q1.

            Zimmer Biomet (ZBH) Beats on Q1 Earnings & Revenue Estimates

            Zimmer Biomet (ZBH) rides on strength in Knee, Hip and S.E.T. segments in Q1.

              Can S.E.T. Aid Zimmer (ZBH) Q1 Earnings Despite Supply Woes?

              Several FDA clearances within S.E.T since last November raise hope for Zimmer Biomet (ZBH) in Q1.

                Supply Delay Hits Zimmer Biomet, Operational Plan Buoys Hope

                Zimmer Biomet's (ZBH) dull Knee sales continue to bother due to slower pace of supply recovery and sales recapture of certain key brands.

                  Urmimala Biswas headshot

                  Trade War Fears Grip MedTech: 3 Stocks on the Line of Fire

                  Chances of a retaliation from China leads to widespread losses in the medical device sector.

                    New Strong Sell Stocks for February 1st

                    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                      Zimmer Biomet (ZBH) Q4 Earnings Meet, Sales Miss Estimates

                      Zimmer Biomet (ZBH) rides high on all segments.

                        Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q4 Earnings?

                        Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q4.

                          Zimmer Biomet Strong on Positive Data From PROGRESS II Study

                          Zimmer Biomet (ZBH) consistently endeavors to improve its knee business.

                            Zimmer Biomet (ZBH) Surges: Stock Moves 6.1% Higher

                            Zimmer Biomet (ZBH) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

                              New Strong Sell Stocks for December 12th

                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                Zimmer Biomet Hurt by Supply Delay, Knee Challenges Remain

                                Zimmer Biomet (ZBH) struggles with supply delay problem related to some of its products, causing inability to win back lost customers and gain new ones.

                                  New Strong Sell Stocks for November 20th

                                  Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                    Zimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales Estimate

                                    Zimmer Biomet (ZBH) posts in line revenues on the back of soft Knees and Hips segments in Q3.

                                      Tracey Ryniec headshot

                                      5 Earnings All-Stars to Start the Week

                                      With over 1,000 companies reporting, these are some of the best earnings charts to start the week.

                                        Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?

                                        Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q3.

                                          Is Zimmer Biomet (ZBH) a Great Stock for Value Investors?

                                          Is Zimmer Biomet (ZBH) a great pick from the value investor's perspective right now? Read on to know more.

                                            Zimmer Biomet (ZBH) Launches Persona Partial Knee System

                                            Zimmer Biomet (ZBH) is constantly trying to turn its Knees business around. Keeping in line with the efforts, the company has launched Persona Partial Knee System.

                                              New Strong Sell Stocks for September 6th

                                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                                Zimmer (ZBH) Plagued by Various Internal and External Issues

                                                Zimmer Biomet (ZBH) continues to suffer a bad patch, entangled with issues including its decade-old CEO's recent exit post a dull earnings season due to poor knee business.

                                                  New Strong Sell Stocks for August 14th

                                                  Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: